Join NeuroOne at the Oppenheimer Healthcare MedTech Conference
NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) is excited to announce its participation in the notable Oppenheimer 35th Annual Healthcare MedTech & Services Conference. This prominent event is designed to illuminate innovations and advancements in the medical technology sector, providing a platform for companies like NeuroOne, focused on enhancing surgical care options.
Anticipation Builds for CEO Dave Rosa's Presentation
Dave Rosa, the Chief Executive Officer of NeuroOne, is set to host a compelling virtual presentation on the important developments in the company's technology. Scheduled for 9:20 a.m. Eastern Time, participants can look forward to an engaging discussion about the state-of-the-art solutions NeuroOne is delivering to improve care for patients grappling with various neurological disorders. This presentation will be inclusive of both live attendance and a replay option, making accessibility a priority.
Understanding NeuroOne's Mission
NeuroOne is steadfast in its commitment to revolutionizing how neurosurgical procedures are conducted. The company is actively developing minimally invasive and high-definition solutions that are set to address neurological conditions such as epilepsy, Parkinson's disease, and essential tremors. By pioneering such solutions, NeuroOne is poised to not only enhance patient outcomes but also to lower procedural costs significantly.
Innovative Solutions and Future Applications
The company's research isn't limited to current applications. In exploring its innovative potential, NeuroOne is actively looking into solutions for other challenging health issues, including mood disorders, chronic pain, incontinence, and high blood pressure. Their work reflects a broader trend in healthcare where advancements in technology are paving the way for better diagnostics and treatments, ensuring patients receive the highest standard of care possible.
Connecting with NeuroOne's Investor Relations
For those interested in deepening their understanding of NeuroOne and its offerings, the company maintains a user-friendly investors relations website featuring comprehensive resources. Here, visitors can access presentations, reports, and the latest updates regarding their innovations. Interested parties may also reach out directly to the Investor Relations team through their dedicated contact information.
Contact Information
If you wish to get in touch with NeuroOne for further information, you may contact Chris Donovan of MZ Group – MZ North America. He is available via email at NMTC@mzgroup.us or by phone at (914) 352-5853. NeuroOne is eager to engage with stakeholders and those interested in learning more about their path forward in medical technology.
Frequently Asked Questions
What is NeuroOne's primary focus?
NeuroOne Medical Technologies is focused on developing minimally invasive and high-definition solutions to improve care for patients with neurological disorders.
Who will represent NeuroOne at the upcoming conference?
CEO Dave Rosa will represent NeuroOne during the presentation at the Oppenheimer Conference.
What types of neurological disorders does NeuroOne address?
The company addresses disorders such as epilepsy, Parkinson’s disease, and essential tremors, among others.
How can I view the conference presentation?
The presentation will be available live and on-demand through NeuroOne’s website.
Who can I contact for more information?
You can contact Chris Donovan at MZ Group for any inquiries regarding NeuroOne.
